Select country
Membership information
0800 561 9000
Medicolegal advice
0800 561 9090
Menu
Refine my search

Recall of typhoid vaccine highlights the importance of documentation

Post date: 12/10/2012 | Time to read article: 1 mins

The information within this article was correct at the time of publishing. Last updated 14/11/2018

The recent recall of a typhoid vaccine because it may not offer full protection, highlights the importance of health professionals accurately recording details of vaccines and batch numbers, says the Medical Protection Society (MPS).1

The medical defence organisation is advising its members to contact those who have received the Typhim Vi vaccine, to help manage any anxieties and provide clear advice on precautions to take whilst abroad.

Dr Pallavi Bradshaw, medicolegal adviser at MPS says, 'This incident highlights the importance of meticulous documentation when prescribing and administering drugs and vaccines, in particular, recording the batch numbers, so that doctors and clinics can identify those individuals who may be affected. It also serves as a reminder for a patient’s full contact information to be recorded by practices and one-stop clinics, and the need for robust governance systems to allow tracing in situations such as these.

Although thankfully, it does not appear as though the vaccine itself poses any health threat, the alert is likely to cause anxiety in many. Doctors have an obligation to provide open and honest information when things go wrong – in this instance, reassuring patients will help allay any fears.

The GMC’s guidance Good Medical Practice states that if a patient has suffered harm or distress, you must act immediately to put matters right. Doctors should be proactive in contacting affected patients, not least to offer advice on other precautions to prevent typhoid when travelling but to check those who may have already travelled.'

Further information

For further information please contact Kim Watson, Press Officer at MPS on +44 207 399 1409 or email [email protected]

Notes to editors

  1. Press release issued by the Medicines and Healthcare products Regulatory Agency (08 October 2012) – Typhoid vaccine batches recalled by manufacturer Sanofi

Share this article

Share
New site feature tour

Introducing an improved
online experience

You'll notice a few things have changed on our website. After asking our members what they want in an online platform, we've made it easier to access our membership benefits and created a more personalised user experience.

Why not take our quick 60-second tour? We'll show you how it all works and it should only take a minute.

Take the tour Continue to site

Medicolegal advice
0800 561 9090
Membership information
0800 561 9000

Key contact details

Should you need to contact us, our phone numbers are always visible.

Personalise your search

We'll save your profession in the "I am a..." dropdown filter for next time.

Tour completed

Now you've seen all of the updated features, it's time for you to try them out.

Continue to site
Take again